Worst way to sleep: The worst thing you can do when you are sniffly is sleep face-down. This puts unnecessary strain on your ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

"Patients diagnosed with headache may benefit from concurrent behavioral health evaluation and treatment," researchers said.

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

Panadol has unveiled sub-brand Panmigrol, aimed at tackling migraine pain.

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

Ibuprofen, a common painkiller, is found to boost memory and intelligence in a University College London study. While some ...

The US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the ...

A study published in The Lancet found that sodium nitrite provoked headaches in eight out of 13 people who consumed it.

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...